Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
Cancer Cell|December 21, 2004
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growthPeiwen Fei, Wenge Wang, Seok-hyun Kim, et al.Cancers|September 10, 2021
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer TreatmentEr Yue, Guangchao Yang, Yuanfei Yao, et al.Cancer Research|October 14, 2010
The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factorsMichael Dews, Jamie L Fox, Stacy Hultine, et al.Environmental Research|April 19, 2021
Meteorological conditions are heterogeneous factors for COVID-19 risk in ChinaShuang Xiao, Hongchao Qi, Michael P Ward, et al.Cancers|December 9, 2023
POLD1 DEDD Motif Mutation Confers Hypermutation in Endometrial Cancer and Durable Response to PembrolizumabChristina Hsiao Wei, Edward Wenge Wang, Lingzi Ma, et al.Critical Reviews in Oncology/Hematology|September 18, 2016
Malignant melanoma-The cradle of anti-neoplastic immunotherapyKristian M Koller, Wenge Wang, Todd D Schell, et al.Brain Communications|July 31, 2026
Safety, tolerability and preliminary efficacy of ALMB-0166 in patients with acute spine cord injuryJinqian Liang, Wei Chen, Fang Zhou, et al.Journal of Clinical Medicine|September 5, 2020
Frontline Management of Epithelial Ovarian Cancer-Combining Clinical Expertise with Community Practice Collaboration and Cutting-Edge ResearchEdward Wenge Wang, Christina Hsiao Wei, Sariah Liu, et al.Science Translational Medicine|February 8, 2013
Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effectsJoshua E Allen, Gabriel Krigsfeld, Patrick A Mayes, et al.Cancer Cell|July 7, 2007
Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced deathM Stacey Ricci, Seok-Hyun Kim, Kazuhiro Ogi, et al.Pageof 8